| Secondary |
| Drug Use For Unknown Indication |
29.4% |
| Product Used For Unknown Indication |
23.5% |
| Peritoneal Dialysis |
17.6% |
| Benign Prostatic Hyperplasia |
5.9% |
| Cardiac Disorder |
5.9% |
| Liver Disorder |
5.9% |
| Oral Herpes |
5.9% |
| Rheumatoid Arthritis |
5.9% |
|
| Application Site Swelling |
16.7% |
| Device Malfunction |
16.7% |
| Drug Interaction |
16.7% |
| Local Swelling |
16.7% |
| Syncope |
16.7% |
| Urine Output Decreased |
16.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.2% |
| Drug Use For Unknown Indication |
17.3% |
| Chronic Obstructive Pulmonary Disease |
10.1% |
| Cardiac Disorder |
8.6% |
| Asthma |
4.8% |
| Gastrooesophageal Reflux Disease |
3.8% |
| Hypertension |
3.4% |
| Blood Cholesterol Increased |
2.9% |
| Rheumatoid Arthritis |
2.7% |
| Breast Cancer |
2.5% |
| Diabetes Mellitus |
2.5% |
| Blood Pressure |
2.1% |
| Atrial Fibrillation |
1.9% |
| Depression |
1.7% |
| Benign Prostatic Hyperplasia |
1.3% |
| Dyspepsia |
1.3% |
| Pain |
1.3% |
| Restless Legs Syndrome |
1.3% |
| Diabetes Mellitus Non-insulin-dependent |
1.1% |
| Hyperlipidaemia |
1.1% |
|
| Myocardial Infarction |
10.4% |
| Flushing |
9.0% |
| Drug Ineffective |
8.2% |
| Product Quality Issue |
8.2% |
| Palpitations |
6.0% |
| Vomiting |
5.2% |
| Pruritus |
4.5% |
| Rash |
4.5% |
| Syncope |
4.5% |
| Weight Decreased |
4.5% |
| Diarrhoea |
3.7% |
| Dizziness |
3.7% |
| Dyspnoea |
3.7% |
| Increased Upper Airway Secretion |
3.7% |
| Nausea |
3.7% |
| Pharmaceutical Product Complaint |
3.7% |
| Weight Increased |
3.7% |
| Accidental Overdose |
3.0% |
| Cardiac Disorder |
3.0% |
| Dysphonia |
3.0% |
|
| Interacting |
| Bipolar I Disorder |
33.3% |
| Cardiac Disorder |
33.3% |
| Hepatitis C |
33.3% |
|
| Adverse Drug Reaction |
50.0% |
| Dyspnoea |
50.0% |
|
